Skip to main content
    C

    CVS Health Corp (CVS)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $85.80
    -2.79 (-3.15%)

    Market Cap: $113.35B

    Last updated: Nov 17, 2026 at 4:40 PM ET

    CVS Health Corp (CVS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    CVS Health (CVS) has a market cap of $113.35B and an enterprise value of $174.99B. Its net debt of $61.64B equals 54.38% of its market cap.

    Total Valuation

    Enterprise value is 54.38% above the market cap, as debt exceeds cash.

    Market Cap$113.35B
    Enterprise Value$174.99B
    Latest price (Nov 17, 2026)$85.80

    Key Dates

    The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 22, 2026.

    Next Earnings DateFeb 8, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Last Ex-Dividend DateOct 22, 2026
    Last Payment DateNov 2, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.23% in the quarter ended Sep 30, 2026 and grew 0.91% a year over 2 years.

    Shares Outstanding1.28B
    Shares Change (YoY)+1.02%
    Shares Change (QoQ)+0.23%
    Share Count Growth (2Y CAGR)+0.91%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 1.4x. Its year-end P/E ranged from 8.3x to 13.5x from 2016 to 2025.

    P/E Ratio10.3x
    Forward P/E10.4x
    P/S Ratio0.3x
    Forward P/S0.3x
    P/B Ratio1.4x
    P/FCF Ratio7.1x
    P/OCF Ratio6.1x
    PEG Ratio0.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 8.7x EBITDA and 11.0x free cash flow.

    EV / Earnings15.8x
    EV / Sales0.4x
    EV / EBITDA8.7x
    EV / EBIT11.5x
    EV / FCF11.0x

    Price Statistics

    The stock is up 11.16% over 52 weeks and trades 3.49% below its 50-day average.

    Beta (1Y)0.00
    52-Week Change+11.16%
    1-Month Change-6.77%
    3-Month Change-7.74%
    6-Month Change-8.33%
    5-Year Change+1.09%
    10-Year Change+7.31%
    Total Return (1Y)+14.60%
    Total Return (3Y CAGR)+10.64%
    Total Return (5Y CAGR)+0.63%
    Return vs SPY (1Y)-0.59%
    Max Drawdown (1Y)-26.74%
    Max Drawdown (3Y)-43.97%
    Sharpe Ratio (1Y)0.30
    Correlation with SPY (1Y)0.00
    50-Day Average$88.90
    200-Day Average$88.52
    52-Week Range$67.99 to $109.22
    RSI (14 Days)44.0
    Average Volume (20 Days)11.68M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.85x current liabilities, and total debt is 0.91x shareholder equity.

    Current Ratio0.85x
    Quick Ratio0.66x
    Debt / Equity0.91x
    Debt / EBITDA3.72x
    Debt / FCF4.71x
    Interest Coverage4.95x

    Returns and Efficiency

    Return on invested capital is 8.99% over the last 12 months, against a 5-year average of 5.44%.

    Return on Equity (ROE)13.72%
    Return on Assets (ROA)4.28%
    Return on Invested Capital (ROIC)8.99%
    Return on Capital Employed (ROCE)9.20%
    ROE (5Y Average)7.20%
    ROA (5Y Average)2.23%
    ROIC (5Y Average)5.44%
    Asset Turnover1.64x
    Inventory Turnover13.08x
    Receivables Turnover10.21x
    Cash Conversion Cycle36 days

    Taxes

    Income tax took 8.85% of pretax income over the last 12 months.

    Income Tax (TTM)$1.07B
    Effective Tax Rate8.85%

    Scores

    CVS has an Altman Z-Score of 2.49, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score2.49
    Altman Z ZoneGrey
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $420.61B over the last 12 months is up 6.73% from the 12 months before.

    Revenue$420.61B
    Revenue Growth (YoY)+6.73%
    Gross Profit$186.06B
    Operating Income$15.06B
    Pretax Income$12.12B
    Net Income$11.05B
    EBITDA$19.70B
    EBIT$15.18B
    Reported EPS (TTM)$8.33

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 31.19% of the $258.07B in total assets.

    Cash and Equivalents$11.74B
    Total Debt$73.38B
    Net Debt$61.64B
    Net Debt Per Share$48.08
    Working Capital-$13.71B
    Shareholder Equity$80.50B
    Book Value Per Share$62.79
    Tangible Book Value-$29.20B
    Total Assets$258.07B
    Total Liabilities$177.39B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3.14B of capital spending, operating cash flow left $15.57B of free cash flow.

    Operating Cash Flow$18.71B
    Capital Expenditures$3.14B
    Free Cash Flow$15.57B
    FCF Per Share$12.17
    Depreciation and Amortization$4.52B
    Dividends Paid$3.42B

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 3.58%, against a 5-year average of 2.86%.

    Gross Margin44.24%
    Operating Margin3.58%
    Pretax Margin2.88%
    Net Margin2.63%
    EBITDA Margin4.68%
    EBIT Margin3.61%
    FCF Margin3.70%
    Gross Margin (5Y Average)37.15%
    Operating Margin (5Y Average)2.86%
    Net Margin (5Y Average)1.62%

    Growth

    Revenue grew 7.63% a year over 3 years, and EPS fell 8.32% a year.

    Revenue Growth (3Y CAGR)+7.63%
    Revenue Growth (5Y CAGR)+8.39%
    EPS Growth (3Y CAGR)-8.32%
    EPS Growth (5Y CAGR)-2.11%
    FCF Growth (3Y CAGR)-16.58%
    FCF Growth (5Y CAGR)-10.28%
    Operating Income Growth (3Y CAGR)-16.32%
    Book Value Per Share Growth (2Y CAGR)-0.20%

    Revenue and profit by year

    Dividends and Yields

    CVS pays out 18.23% of earnings as dividends.

    Dividend Per Share (Annual)$2.66
    Dividend Yield3.10%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+6.53%
    Dividend Growth (5Y CAGR)+5.87%
    Payout Ratio18.23%
    FCF Payout Ratio21.99%
    Earnings Yield9.71%
    FCF Yield14.15%
    Shareholder Yield3.11%

    Full dividend history

    Stock Splits

    The last split was a 2-for-1 forward split on Jun 7, 2005.

    Last Split DateJun 7, 2005
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 12 similar companies, CVS has the 11th highest P/E and the 11th highest P/S.

    P/E Ratio10.3x vs 17.9x median
    P/S Ratio0.3x vs 0.5x median
    ROIC8.99% vs 13.95% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.73% vs +8.95% median
    Dividend Yield3.10% vs 0.68% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 3.52% and EPS growth at 13.42% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+3.52%
    EPS Growth Forecast (2Y CAGR)+13.42%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CVS

    What is CVS's market cap?

    CVS Health has a market cap of $113.35B. Its enterprise value, which adds debt and subtracts cash, is $174.99B.

    What is CVS's P/E ratio?

    CVS Health has a trailing P/E ratio of 10.3x and a forward P/E of 10.4x.

    How many shares of CVS are outstanding?

    CVS Health has 1.28B shares outstanding. The count is up 1.02% from a year earlier.

    Does CVS pay a dividend?

    Yes. CVS Health pays $2.66 a share a year, a dividend yield of 3.10%.

    How much debt does CVS have?

    CVS Health has $73.38B of total debt and $11.74B of cash and equivalents, a net debt position of $61.64B.